Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index on Patients Undergoing Primary Percutaneous Coronary Intervention

NCT07203573 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07203573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07203573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index on Patients Undergoing Primary Percutaneous Coronary Intervention
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 25, 2025
Completion date
October 25, 2026
Enrollment
140 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary percutaneous coronary intervention